Bovine Serum Albumin Dialysis Removes Protein-Bound Toxins from Human Serum Albumin Solution: Theory and Benchtop Validation
Blood Purification · 2026
DOI: 10.1159/000550546 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Blood Purification, 2026. Verfasst von Alexander Novokhodko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mechanical Engineering, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Serum Albumin, Bovine, Dialysis Solutions, Renal Dialysis, Toxins, Biological.
Abstract (Originalsprache)
Introduction
Adding a binder to dialysate improves the removal of protein bound toxins (PBTs). Systems that use dialysate with human serum albumin (HSA) to remove PBTs show promise for improving treatment in liver failure and other fields. HSA-based systems are difficult to scale due to scarce donor blood and expensive recombinant options. We investigate bovine serum albumin (BSA) as an alternative.
Methods
Computational modeling predicted the impact of dialysate side BSA concentration on the removal of three PBTs (bilirubin, cholic acid, and indoxyl sulfate). We validated our predictions using a blood analog solution with HSA and PBTs. This solution was dialyzed against dialysate with BSA at various concentrations. HSA dialysate was tested as a positive control.
Results
The model accurately predicts toxin removal. For bilirubin removal, the percent error of the prediction is less than 6%. For cholic acid and indoxyl sulfate, the percent error is higher because final concentration values are small. However, the square root of the sum of squares error of the prediction did not exceed 0.13 mg/g and 0.25 mg/g, respectively. PBT removal by BSA matched or exceeded results observed with HSA. The model accurately predicted the benefit of increased BSA concentration.
Conclusions
This model will allow binder dialysis optimization, enabling personalized dialysis dosing for maximum PBT removal. Using BSA can overcome the scarcity of HSA, enabling large scale treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mechanical Engineering, University of Washington, Seattle, Washington, USA.
- School of Engineering & Technology, University of Washington, Tacoma, Washington, USA.
- Chemistry, University of Washington, Seattle, Washington, USA.
- School of Medicine, University of Washington, Seattle, Washington, USA, sahmad@uw.edu.
- Mechanical Engineering, University of Washington, Seattle, Washington, USA, dayong@uw.edu.
Zitieren
APA
Novokhodko, A., Du, N., Hao, S., Wang, Z., Shu, Z., Sadilek, M., Ahmad, S., & Gao, D. (2026). Bovine Serum Albumin Dialysis Removes Protein-Bound Toxins from Human Serum Albumin Solution: Theory and Benchtop Validation. Blood Purification. https://doi.org/10.1159/000550546
Vancouver
Novokhodko A, Du N, Hao S, Wang Z, Shu Z, Sadilek M, et al. Bovine Serum Albumin Dialysis Removes Protein-Bound Toxins from Human Serum Albumin Solution: Theory and Benchtop Validation. Blood Purification. 2026. doi:10.1159/000550546
BibTeX
@article{Novokhodko2026,
author = {Novokhodko, Alexander and Du, Nanye and Hao, Shaohang and Wang, Ziyuan and Shu, Zhiquan and Sadilek, Martin and Ahmad, Suhail and Gao, Dayong},
title = {Bovine Serum Albumin Dialysis Removes Protein-Bound Toxins from Human Serum Albumin Solution: Theory and Benchtop Validation},
journal = {Blood Purification},
year = {2026},
doi = {10.1159/000550546}
}
EUVIMED